Literature DB >> 2137033

Surfaces of murine lymphocyte subsets differ in sialylation states and antigen distribution of a major N-linked penultimate saccharide structure.

S W Whiteheart1, J C McLenithan, G W Hart.   

Abstract

Rat liver beta-galactoside alpha-2,6-sialyltransferase and Vibrio cholerae sialidase were used with cytidine-5'-monophospho-N-acetyl-[3H]neuraminic acid (CMP-[3H]NeuAc) to specifically probe the distribution and sialylation state of Gal beta 1-4GlcNAc residues on N-linked saccharides on the surfaces of murine lymphocytes. The relative extent of exogenous sialyltransferase-mediated sialylation (per cellular protein) was thymocytes greater than T-cells greater than T-cell lymphoma (EL-4) greater than B-cells greater than B-cell lymphoma (AKTB-1b) greater than splenocytes. Prior desialylation increased exogenous resialylation by 23.8-, 13.1-, 7.1-, 7.9-, 7.0-, and 5.3-fold for splenocytes, B-cells, T-cells, EL-4, AKTB-1b, and thymocytes, respectively. Though numerous glycoproteins were labeled, the majority of the Gal beta 1-4GlcNAc residues were detected on a relatively small number of cell surface proteins, many of which are well-defined lymphocyte antigens. Gal beta 1-4GlcNAc residues on thymocytes were found to exist in an undersialylated state on T200 but not on other antigens (e.g., Thy-1). T200 was found to be fully sialylated on mature cells (i.e., hydrocortisone-resistant thymocytes and splenic T-cells), suggesting that its sialylation state is developmentally regulated. These studies indicate that the number, sialylation state, and polypeptide distribution of the penultimate structure, Gal beta 1-4GlcNAc, differ on N-linked saccharides on the surfaces of different lymphocyte populations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137033     DOI: 10.1016/0008-8749(90)90089-a

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.

Authors:  Haruko Ogawa; Uri Galili
Journal:  Glycoconj J       Date:  2006-11-18       Impact factor: 2.916

2.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.

Authors:  B J Bast; L J Zhou; G J Freeman; K J Colley; T J Ernst; J M Munro; T F Tedder
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

3.  Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody.

Authors:  H J Gabius; B Wosgien; M Hendrys; A Bardosi
Journal:  Histochemistry       Date:  1991

4.  Generation of mice deficient for macrophage galactose- and N-acetylgalactosamine-specific lectin: limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins.

Authors:  Thandi M Onami; Meei-Yun Lin; Dawne M Page; Shirley A Reynolds; Carol D Katayama; Jamey D Marth; Tatsuro Irimura; Ajit Varki; Nissi Varki; Stephen M Hedrick
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  Stimulation of human peripheral blood mononuclear cells by the sialic acid precursor N-propanoylmannosamine.

Authors:  Cora Roehlecke; Rüdiger Horstkorte; Werner Reutter
Journal:  Glycoconj J       Date:  2013-06-30       Impact factor: 2.916

6.  The glycosylation status of murine [corrected] postnatal thymus: a study by histochemistry and lectin blotting.

Authors:  Erdal Balcan; Ayça Gümüş; Mesut Sahin
Journal:  J Mol Histol       Date:  2008-07-19       Impact factor: 2.611

7.  Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.

Authors:  Lei Jin; Paul A McLean; Benjamin G Neel; Henry H Wortis
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

8.  Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells.

Authors:  L G Baum; M Pang; N L Perillo; T Wu; A Delegeane; C H Uittenbogaart; M Fukuda; J J Seilhamer
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.